SynthesisInternational immunopharmacology2021

Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials.

Ching-Yi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.